Dronedarone - Wikipedia

Dronedarone (development codename SR33589 and marketed as Multaq) is a drug by Sanofi-Aventis, mainly for the indication of cardiac arrhythmias. It was approved by ...

Dronedarone Uses, Side Effects & Warnings - Drugs.com

Physician reviewed dronedarone patient information - includes dronedarone description, dosage and directions.

MULTAQ - Dronédarone - Posologie, Effets secondaires ...

MULTAQ : MULTAQ est indiqué pour le maintien du rythme sinusal après une cardioversion réussie chez les patients adultes cliniquement stables atteints de ...

ATRIAL FIBRILLATION: Dronedarone and Amiodarone-- Safety ...

Amiodarone effectively maintains sinus rhythm in patients with atrial fibrillation, but although dronedarone is less effective it has a better safety profile.

新藥 Dronedarone 應用於心房纖維 顫動和心房 ...

第28卷第1期 Mar. 31 2012 新藥 Dronedarone 應用於心房纖維顫動和心房撲動之治療 藥學雜誌 第110冊 33 繼續教育 但不含碘，可降低對 ...

Multaq 400mg tablets - Summary of Product Characteristics ...

Careful monitoring during dronedarone administration is recommended by regular assessment of cardiac, hepatic and pulmonary function (see below).

Reference ID: 2964101 - Food and Drug Administration

5.4 QT Interval Prolongation . Dronedarone induces a moderate (average of about 10 ms but much greater effects have been observed) QTc (Bazett) prolongation

Common Side Effects of Multaq (Dronedarone Tablets) Drug ...

Find a comprehensive guide to possible side effects including common and rare side effects when taking Multaq (Dronedarone Tablets) for healthcare professionals and ...

MULTAQ® (dronedarone) Tablets Prescribing Information

Dronedarone is metabolized by CYP 3A and is a moderate inhibitor of CYP 3A and CYP 2D6 and has potentially important pharmacodynamic interactions . Class I or III ...

What Everyone with Atrial Fibrillation Should Know about ...

StopAfib examines the pros and cons of Multaq (dronedarone) for atrial fibrillation (afib)